Participants were randomised after eligibility assessment
and consent was taken. An independent statistician prepared
random block sizes of between two and eight to
ensure balance of trial arms. Researchers obtained informed
consent from patients and then, using opaque
sealed envelopes, randomly allocated participants to
their treatment group.